Share：
Share this content in WeChat
X
[Chinese][PDF]98968
• Review •
Research progress of functional magnetic resonance imaging in chronic kidney disease
MA Xiaomei  HE Jianwei  CHANG Feixia  JIA Yingmei  WANG Lili  GAO Bo  HUANG Gang 

Cite this article as: Ma XM, He JW, Chang FX, et al. Research progress of functional magnetic resonance imaging in chronic kidney disease. Chin J Magn Reson Imaging, 2020, 11(10): 950-953. DOI:10.12015/issn.1674-8034.2020.10.030.


[Abstract] Chronic kidney disease (CKD), characterized by high incidence, poor health outcomes and high treatment costs, imposes a huge burden on individuals and society. Renal tubulointerstitial fibrosis and renal medulla hypoxia are believed to be the main causes of CKD progression. At present, ultrasound-guided renal biopsy is the gold standard for the evaluation and diagnosis of renal fibrosis. However, it is difficult to carry out follow-up monitoring in clinical practice because it is an invasive test with certain side effects and poor repeatability. MRI can provide information about tissue structure noninvasively, and advances in MRI functional imaging techniques offer promise for unique insights into renal function and fibrosis severity, but its potential to assess fibrosis and inflammation in diseased kidneys remains unclear. This paper reviews the research progress of functional magnetic resonance imagingin the diagnosis of chronic kidney disease.
[Keywords] functional magnetic resonance imaging；chronic kidney disease；renal fibrosis

MA Xiaomei Department of Radioligy, Gansu Province Hospital, Lanzhou 730000, China

HE Jianwei Department of Radioligy, Gansu Province Hospital, Lanzhou 730000, China

CHANG Feixia Department of Radioligy, Dunhuang City Hospital, Dunhuang 736200, China

JIA Yingmei Department of Radioligy, Gansu Province Hospital, Lanzhou 730000, China

WANG Lili Department of Radioligy, Gansu Province Hospital, Lanzhou 730000, China

GAO Bo Department of Radioligy, Gansu Province Hospital, Lanzhou 730000, China

HUANG Gang* Department of Radioligy, Gansu Province Hospital, Lanzhou 730000, China

*Correspondence to: Huang G, E-mail: keen0999@163.com

Conflicts of interest   None.

Received  2020-04-05
Accepted  2020-06-23
DOI: 10.12015/issn.1674-8034.2020.10.030
Cite this article as: Ma XM, He JW, Chang FX, et al. Research progress of functional magnetic resonance imaging in chronic kidney disease. Chin J Magn Reson Imaging, 2020, 11(10): 950-953. DOI:10.12015/issn.1674-8034.2020.10.030.

[1]
Chevalier RL. Evolutionary nephrology. Kidney Int Rep, 2017, 2(3): 302-317.
[2]
Szeto SG, Narimatsu M, Lu M, et al. Yap/taz are mechanoregulators of tgf-β-smad signaling and renal fibrogenesis. J Am Soc Nephrol, 2016, 27(10): 3117-3128.
[3]
Brown CA, Elliott J, Schmiedt CW, et al. Chronic kidney disease in aged cats: Clinical features, morphology, and proposed pathogeneses. Vet Pathol, 2016, 53(2): 309-326.
[4]
Tanaka T. A mechanistic link between renal ischemia and fibrosis. Med Molecul Morphology, 2017, 50(1): 1-8.
[5]
Romagnani P, Remuzzi G, Glassock R, et al. Chronic kidney disease. Nat Rev Dis Primers, 2017, 55(Suppl 2): S116-117.
[6]
Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: From hypothesis to novel therapeutics. Kidney Int, 2008, 74(7): 867-872.
[7]
Hayer MK, Price AM, Liu B, et al. Diffuse myocardial interstitial fibrosis and dysfunction in early chronic kidney disease. Am J Cardiol, 2018, 121(5): 656-660.
[8]
Guzzi F, Cirillo L, Roperto RM, et al. Molecular mechanisms of the acute kidney injury to chronic kidney disease transition: An updated view. Int J Mol Sci, 2019, 20(19):4941.
[9]
Breyer MD, Susztak K. The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov, 2016, 15(8): 568-588.
[10]
Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol, 2005, 16(Suppl 1): S30-33.
[11]
Leung G, Kirpalani A, Szeto SG, et al. Could mri be used to image kidney fibrosis? A review of recent advances and remaining barriers. Clin J Am Soc Nephrol, 2017, 12(6): 1019-1028.
[12]
Esposito V, Mazzon G, Baiardi P, et al. Safety and adequacy of percutaneous kidney biopsy performed by nephrology trainees. BMC nephrology, 2018, 19(1): 14-15.
[13]
Redfield RR, McCune KR, Rao A, et al. Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsy. Transpl Int, 2016, 29(2): 167-172.
[14]
Walker PD. The renal biopsy. Archives Pathology & Lab Med, 2009, 133(2): 181-188.
[15]
Kholmovski EG, Morris AK, Chelu MG. Cardiac mri and fibrosis quantification. Card Electrophysiol Clin, 2019, 11(3): 537-549.
[16]
Ciepłucha A, Trojnarska O, Kociemba A, et al. Clinical aspects of myocardial fibrosis in adults with ebstein's anomaly. Heart Vessels, 2018, 33(9): 1076-1085.
[17]
Layne KA, Dargan PI, Archer JRH, et al. Gadolinium deposition and the potential for toxicological sequelae-a literature review of issues surrounding gadolinium-based contrast agents. Br J Clin Pharmacol, 2018, 84(11): 2522-2534.
[18]
Grenier N, Merville P, Combe C. Radiologic imaging of the renal parenchyma structure and function. Nat Rev Nephrol, 2016, 12(6): 348-359.
[19]
Zhang J, Zhang LJ. Functional mri as a tool for evaluating interstitial fibrosis and prognosis in kidney disease. Kidney Dis (Basel, Switzerland), 2020, 6(1): 7-12.
[20]
Jiang K, Ferguson CM, Ebrahimi B, et al. Noninvasive assessment of renal fibrosis with magnetization transfer mr imaging: Validation and evaluation in murine renal artery stenosis. Radiology, 2017, 283(1): 77-86.
[21]
Ebrahimi B, Textor S, Lerman LO. Renal relevant radiology: Renal functional magnetic resonance imaging. Clin J Am Soc Nephrol, 2014, 9(2): 395-405.
[22]
Feng Q, Ma Z, Wu J, et al. Dti for the assessment of disease stage in patients with glomerulonephritis-correlation with renal histology. Eur Radiol, 2015, 25(1): 92-98.
[23]
Wittsack HJ, Lanzman RS, Mathys C, et al. Statistical evaluation of diffusion-weighted imaging of the human kidney. Magn Reson Med, 2010, 64(2): 616-622.
[24]
Liu Z, Xu Y, Zhang J, et al. Chronic kidney disease: Pathological and functional assessment with diffusion tensor imaging at 3t mr. Eur Radiol, 2015, 25(3): 652-660.
[25]
Caroli A, Schneider M, Friedli I, et al. Diffusion-weighted magnetic resonance imaging to assess diffuse renal pathology: A systematic review and statement paper. Nephrology Dialysis Transplantation, 2018, 33(Suppl 2): 29-40.
[26]
Ding J, Chen J, Jiang Z, et al. Assessment of renal dysfunction with diffusion-weighted imaging: Comparing intra-voxel incoherent motion (ivim) with a mono-exponential model. Acta Radiologica, 2016, 57(4): 507-512.
[27]
Emre T, Kiliçkesmez Ö, Büker A, et al. Renal function and diffusion-weighted imaging: A new method to diagnose kidney failure before losing half function. La Radiologia Medica, 2016, 121(3): 163-172.
[28]
Togao O, Doi S, Kuroo M, et al. Assessment of renal fibrosis with diffusion-weighted mr imaging: Study with murine model of unilateral ureteral obstruction. Radiology, 2010, 255(3): 772-780.
[29]
Mao W, Zhou J, Zeng M, et al. Intravoxel incoherent motion diffusion-weighted imaging for the assessment of renal fibrosis of chronic kidney disease: A preliminary study. Magn Reson Imaging, 2018, 47: 118-124.
[30]
Feng YZ, Chen XQ, Yu J, et al. Intravoxel incoherent motion (ivim) at 3.0 T: Evaluation of early renal function changes in type 2 diabetic patients. Abdominal Radiol (New York), 2018, 43(10): 2764-2773.
[31]
Deng Y, Yang B, Peng Y, et al. Use of intravoxel incoherent motion diffusion-weighted imaging to detect early changes in diabetic kidneys. Abdominal Radiol (New York), 2018, 43(10): 2728-2733.
[32]
Mao W, Zhou J, Zeng M, et al. Chronic kidney disease: Pathological and functional evaluation with intravoxel incoherent motion diffusion-weighted imaging. J Magn Reson Imaging, 2018, 47(5): 1251-1259.
[33]
Sabour S, Batari H. Conventional MRI combined with dti for neonatal hyperbilirubinemia; methodological issues on diagnostic value. Pediatr Neonatol, 2018, 59(6): 638-639.
[34]
Trip AK, Jensen MB, Kallehauge JF, et al. Individualizing the radiotherapy target volume for glioblastoma using DTI-MRI: A phase 0 study on coverage of recurrences. Acta Oncol, 2019, 58(10): 1532-1535.
[35]
Feng YZ, Ye YJ, Cheng ZY, et al. Non-invasive assessment of early stage diabetic nephropathy by dti and bold MRI. British J Radiol, 2020, 93(1105): 20190562.
[36]
Ogawa S, Lee TM, Kay AR, et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proceed National Acad Sci, 1990, 87(24): 9868-9872.
[37]
Eckardt KU, Bernhardt WW, Weidemann A, et al. Role of hypoxia in the pathogenesis of renal disease. Blood Purification, 2003, 21(3): 253-257.
[38]
Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with bold MRI. Circulation, 1996, 94(12): 3271-3275.
[39]
Yin WJ, Liu F, Li XM, et al. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by bold-MRI. Eur J Radiol, 2012, 81(7): 1426-1431.
[40]
Feng YZ, Ye YJ, Cheng ZY, et al. Non-invasive assessment of early stage diabetic nephropathy by DTI and bold MRI. Br J Radiol, 2020, 93(1105): 20190562.
[41]
Artz NS, Wentland AL, Sadowski EA, et al. Comparing kidney perfusion using noncontrast arterial spin labeling mri and microsphere methods in an interventional swine model. Investigative Radiol, 2011, 46(2): 124-131.
[42]
Ritt M, Janka R, Schneider MP, et al. Measurement of kidney perfusion by magnetic resonance imaging: Comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant, 2010, 25(4): 1126-1133.
[43]
Sun Q, Baues M, Klinkhammer BM, et al. Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis. Sci Transl Med, 2019, 11(486): 4865.
[44]
Heusch P, Wittsack HJ, Blondin D, et al. Functional evaluation of transplanted kidneys using arterial spin labeling mri. J Magnetic Reson Imaging, 2014, 40(1): 84-89.
[45]
Artz NS, Sadowski EA, Wentland AL, et al. Arterial spin labeling MRI for assessment of perfusion in native and transplanted kidneys. Magn Reson Imaging, 2011, 29(1): 74-82.
[46]
Brown RS, Sun MRM, Stillman IE, et al. The utility of magnetic resonance imaging for noninvasive evaluation of diabetic nephropathy. Nephrology Dialysis Transplantation, 2019, 23: 66.
[47]
Nery F, De Vita E, Clark CA, et al. Robust kidney perfusion mapping in pediatric chronic kidney disease using single-shot 3D-grase asl with optimized retrospective motion correction. Magn Reson Med, 2019, 81(5): 2972-2984.
[48]
Georges PC, Hui JJ, Gombos Z, et al. Increased stiffness of the rat liver precedes matrix deposition: Implications for fibrosis. Am J Physiol, 2007, 293(6): G1147-G1154.
[49]
Yin M, Chen J, Glaser KJ, et al. Abdominal magnetic resonance elastography. Topics in Magn Reson Imaging, 2009, 20(2): 79-87.
[50]
Rouvière O, Souchon R, Pagnoux G, et al. Magnetic resonance elastography of the kidneys: Feasibility and reproducibility in young healthy adults. J Magn Reson Imaging, 2011, 34(4): 880-886.
[51]
Tan CH, Venkatesh SK. Magnetic resonance elastography and other magnetic resonance imaging techniques in chronic liver disease: Current status and future directions. Gut and liver, 2016, 10(5): 672-686.
[52]
Korsmo MJ, Ebrahimi B, Eirin A, et al. Magnetic resonance elastography noninvasively detects in vivo renal medullary fibrosis secondary to swine renal artery stenosis. Investigative Radiol, 2013, 48(2): 61-68.
[53]
Jiang K, Ferguson CM, Woollard JR, et al. Magnetization transfer magnetic resonance imaging noninvasively detects renal fibrosis in swine atherosclerotic renal artery stenosis at 3.0 T. Investigative Radiol, 2017, 52(11): 686-692.
[54]
Friedli I, Crowe LA, Berchtold L, et al. New magnetic resonance imaging index for renal fibrosis assessment: A comparison between diffusion-weighted imaging and T1 mapping with histological validation. Sci Rep, 2016, 21(6): 30088.

PREV Research progress of neoadjuvant radiotherapy and chemotherapy for rectal cancer based on magnetic resonance imaging radiology
NEXT The application of 19F-MR molecular imaging in targeted drug delivery
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn